Inhibitory effect of novel internalized fully human phage antibody fragments on proliferation of lung adenocarcinoma cell line overexpressing peroxiredoxin I

Chinese Journal of Cancer

Volumn 28, Issue 10, 2009, Pages

  Luo, Yi ^a   Pang, Hua ^a   Li, Shu Jie ^a   Cao, Hui ^a   Li, Shao Lin ^a   Fan, Chun bo ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Lung neoplasm; Peroxiredoxin I; Phage antibody library; Proliferation inhibition; Single chain variable fragment

Indexed keywords

PEROXIREDOXIN 1; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; TETRAZOLIUM;

ANTIBODY AFFINITY; ANTIBODY SCREENING; ANTIBODY SPECIFICITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE CONSTRUCT; GENE INSERTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LUNG ADENOCARCINOMA; MOLECULAR CLONING; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 79955468297     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.009.10081     Document Type: Article

References (21)

1. Manevich Y, Sweitzer T, Pak JH, et al. 1-Cys peroxiredoxin overexpression protects cells against phospholipid peroxidation-mediated membrane damage [J]. PANS, 2002, 99 (18): 11599-11604.
2. Kim HJ, Chae HZ, Kim YJ, et al. Preferential elevation of Prx I and Trx expression in lung cancer cells following hypoxia and in human lung cancer tissues [J]. Cell Biol Toxicol, 2003, 19(5): 285-298.
3. Chang JW, Jeon HB, Lee JH, et al. Augmented expression of Peroxiredoxin I in lung cancer [J]. Biochem Biophy Res Commun, 2001, 289(2): 507-512.
4. Chen MF, Keng PC, Shau H, et al. Inhibition of lung tumor growth and augmentation of radiosensitivity by decreasing peroxiredoxin I expression [J]. Int J Radiat Oncol Biol Phys, 2006, 64(2): 581-591.
5. Kim YJ, Ahn JY, Liang P, et al. Human prx I gene is a target of Nrf 2 and is up-regulated by hypoxia/reoxygenation: implication to tumor biology [J]. Cancer Res, 2007, 67 (2): 546-554.
6. 125I-radiolabeled humanized CC49 monoclonal antibody (HuCC49deltaC (H)2) in recurrent and metastatic colorectal cancer patients [J]. Cancer Biother Radiopharm, 2005, 20(1): 16-26.
7. Weiner LM. Fully human therapeutic monoclonal antibodies [J]. J Immunother, 2006, 29(1): 1-9.
8. Pang H, Luo Y, Li SL. Construction of gene library of human-originated single-chain variable fragment antibody associated with lung adenocarcinoma [J]. J Chongqing Med Univ, 2008, 33 (11): 1284-1287. [in Chinese]
9. Deng XK, Nesbit LA, Morrow KJ. Recombinant single-chain variable fragment antibodies directed against clostridium difficile toxin B produced by use of an optimized phage display system [J]. Clin Diagn Lab Immunol, 2003, 10(4): 587-595.
10. Nonn L, Berggren M, Powis G. Increased expression of mitochondrial peroxiredoxin-3 (thioredoxin peroxidase-2) protects cancer cells against hypoxia and drug-induced hydrogen peroxide-dependent apoptosis [J]. Mol Cancer Res, 2003, 1(9): 682-689.
11. Kim JH, Bogner PN, Baek SH, et al. Up-regulation of peroxiredoxin 1 in lung cancer and its implication as a prognostic and therapeutic target [J]. Clin Cancer Res, 2008, 14(8): 2326-2333.
12. Yip YL, Hawkins NJ, Clark MA, et al. Evaluation of different lymphoid tissue sources for the construction of human immunoglobulin gene libraries [J]. Immunotechnology, 1997, 3 (3): 195-203.
13. Figini M, Obici L, Mezzanzanica D, et al. Panning phage antibody libraries on cells: isolation of human Fab fragments against ovarian carcinoma using guided selection [J]. Cancer Res, 1998, 58(5): 991-996.
14. Heitner T, Satozawa N, McLean K, et al. Obligate multivalent recognition of cell surface tomoregulin following selection from a multivalent phage antibody library [J]. J Biomol Screen, 2006, 11(8): 985-995.
15. Souriau C, Rothacker J, Hoogenboom HR, et al. Human antibody fragments specific for the epidermal growth factor receptor selected from large non-immunised phage display libraries [J]. Growth Factors, 2004, 22(3): 185-194.
16. Velappan N, Martinez JS, Valero R, et al. Selection and characterization of scFv antibodies against the Sin Nombre hantavirus nucleocapsid protein [J]. J Immunol Methods, 2007, 321(1-2): 60-69.
17. Kioi M, Seetharam S, Puri RK. Targeting IL-13Ralpha2-positive cancer with a novel recombinant immunotoxin composed of a single-chain antibody and mutated Pseudomonas exotoxin [J]. Mol Cancer Ther, 2008, 7(6): 1579-1587.
18. Mechaly A, Zahavy E, Fisher M. Development and implementation of a single-chain Fv antibody for specific detection of Bacillus anthracis spores [J]. Appl Environ Microbiol, 2008, 74(3): 818-822.
19. Natha R, Hortobάgyi GN, Esteva FJ. Growth factor receptors in breast cancer: potential for therapeutic intervention [J]. The Oncologist, 2003, 8(1): 5-17.
20. Burtrum D, Zhu Z, Lu D, et al. A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo [J]. Cancer Res, 2003, 63(24): 8912-8921.
21. Liu B, Conrad F, Cooperberg MR, et al. Mapping tumor epitope space by direct selection of single-chain Fv antibody libraries on prostate cancer cells [J]. Cancer Res, 2004, 64 (2): 704-710.